en

PRODUCT DETAIL

Eltrombopag Krka 25 mg filmom obalené tablety

Code 8173E
MA number 16/0316/24-S
Product Form: tbl flm 84x25 mg (blis.OPA/Al/PVC//Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: KRKA, d.d., Novo mesto, Slovenia
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B LOCAL HEMOSTATICS, COMBINATIONS
B02BX Other systemic hemostatics
B02BX05 Eltrombopag
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 02.12.2024
Validity: 02.12.2029
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Eltrombopag Krka_11.2024.pdf  
PIL: PIL_Eltrombopag Krka_11.2024.pdf  
Safety feature Yes
Data update: 04.12.2024
eu-flag.png sk-flag.png